Vision Statement for Multiple Myeloma: Future Directions

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Significant advancements in multiple myeloma management have been achieved with novel agents like immunomodulatory drugs and proteasome inhibitors.
• Despite progress, there remains an urgent need for new therapeutic strategies to further improve patient outcomes.

Purpose of the Study:

• To identify and discuss three key vulnerabilities in multiple myeloma for novel therapeutic targeting.
• To explore the potential of early intervention in smouldering multiple myeloma to alter disease trajectory.

Main Methods:

• Review of current therapeutic landscape and identification of emerging targets in multiple myeloma.
• Analysis of biological pathways including protein degradation (ubiquitin-proteasome and aggresome), autologous immunity, and DNA damage response in myeloma cells.

Main Results:

• Three critical vulnerabilities identified: 1) protein degradation pathways, 2) restoration of antimyeloma immunity, and 3) targeting aberrant biology from DNA damage.
• Early application of therapies targeting these vulnerabilities, particularly in smouldering multiple myeloma, shows promise.

Conclusions:

• Targeting these specific vulnerabilities offers a promising avenue for novel multiple myeloma therapies.
• Early therapeutic intervention has the potential to significantly alter the natural history of multiple myeloma, potentially leading to a chronic and curable disease state.